Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
β-1,3/1,6-D-Glucan in Cardiometabolic Syndrome
NCT05079529Phase 2Unknown
- Sponsor
- Brawijaya University
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Polysaccharide, Dietary Supplement
- Countries
- 1
01
Overview
A Phase 2 trial of beta-1,3/1,6-d-glucan in metabolic syndrome, sponsored by Brawijaya University. Status: unknown.
02
Drugs
beta-1,3/1,6-d-glucan
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT05079529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079529.